Mathematically modeling the involvement of axons in Leber's hereditary optic neuropathy

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 12, 2012, Pages 7608-7617

  Pan, Billy X ^a   Ross Cisneros, Fred N ^a   Carelli, Valerio ^a,b,c   Rue, Kelly S ^a   Salomao, Solange R ^d   Moraes Filho, Milton N ^e   Moraes, Milton N ^e   Berezovsky, Adriana ^d   Belfort, Rubens ^d   Sadun, Alfredo A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b IRCCS ISTITUTO DELLE SCIENZE NEUROLOGICHE DI BOLOGNA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^e Instituto de Olhos de Colatina   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN;

ADULT; AGED; ARTICLE; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LEBER HEREDITARY OPTIC NEUROPATHY; MALE; MATHEMATICAL MODEL; MICROSCOPY; MORPHOMETRICS; OPTIC NERVE FIBER; PRIORITY JOURNAL; COMPARATIVE STUDY; DISEASE COURSE; MATHEMATICS; MIDDLE AGED; NERVE FIBER; OPTIC NERVE; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; RETINA GANGLION CELL; THEORETICAL MODEL;

AGED; AXONS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MATHEMATICS; MIDDLE AGED; MODELS, THEORETICAL; OPTIC ATROPHY, HEREDITARY, LEBER; OPTIC NERVE; RETINAL GANGLION CELLS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84872189044     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10452     Document Type: Article

References (53)

1. Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science. 1988;242:1427-1430.
2. Carelli V, Ross-Cisneros FN, Sadun AA. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res. 2004;23:53-89.
3. Fraser JA, Biousse V, Newman NJ. The neuro-ophthalmology of mitochondrial disease. Surv Ophthalmol. 2010;55:299-334.
4. Yu-Wai-Man P, Griffiths PG, Chinnery PF. Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies. Prog Retin Eye Res. 2011;30:81-114.
5. Shulman RG, Hyder F, Rothman DL. Cerebral metabolism and consciousness. C R Biol. 2003;326:253-273.
6. Raichle ME, Gusnard DA. Appraising the brain's energy budget. Proc Nat Acad Sci U S A. 2002;99:10237-10239.
7. Yu DY, Cringle SJ. Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease. Prog Retin Eye Res. 2001;20; 175-208.
8. Andrews RM, Griffiths PG, Johnson MA, Turnbull DM. Histochemical localisation of mitochondrial enzyme activity in human optic nerve and retina. Br J Ophthalmol. 1999;83; 231-235.
9. Bristow EA, Griffiths PG, Andrews RM, Johnson MA, Turnbull DM. The distribution of mitochondrial activity in relation to optic nerve structure. Arch Ophthalmol. 2002; 120:791-796.
10. Sabri MI, Ochs S. Relation of ATP and creatine phosphate to fast axoplasmic transport in mammalian nerve. J Neurochem. 1972;19:2821-2828.
11. Ochs S, Hollingsworth D. Dependence of fast axoplasmic transport in nerve on oxidative metabolism. J Neurochem. 1971;18:107-114.
12. Sadun AA. Mitochondrial optic neuropathies. J Neurol Neuro-surg Psychiatry. 2002;72:423-425.
13. Sadun A. Acquired mitochondrial impairment as a cause of optic nerve disease. Trans Am Ophthalmol Soc. 1998;96:881-923.
14. Carelli V, Ross-Cisneros FN, Sadun AA. Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies. Neurochem Int. 2002;40:573-584.
15. Sadun AA, Win PH, Ross-Cisneros FN, Walker SO, Carelli V. Leber's hereditary optic neuropathy differentially affects smaller axons in the optic nerve. Trans Am Ophthalmol Soc. 2000;98:223-232; discussion 232-235.
16. Gualtieri M, Bandeira M, Hamer RD, et al. Psychophysical analysis of contrast processing segregated into magnocellular and parvocellular systems in asymptomatic carriers of 11778 Leber's hereditary optic neuropathy. Vis Neurosci. 2008;25: 469-474.
17. Livingstone MS, Hubel DH. Psychophysical evidence for separate channels for the perception of form, color, movement, and depth. J Neurosci. 1987;7:3416-3468.
18. DeLuca GC, Ebers GC, Esiri MM. Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts. Brain. 2004;127:1009-1018.
19. Sadun AA, La Morgia C, Carelli V. Leber's hereditary optic neuropathy: new quinone therapies change the paradigm. Expert Rev Ophthalmol. 2012;7:251-259.
20. Sadun AA, Carelli V, Salomao SR, et al. A very large Brazilian pedigree with 11778 Leber's hereditary optic neuropathy. Trans Am Ophthalmol Soc. 2002;100:169-178; discussion 178-179.
21. Sadun F, De Negri AM, Carelli V, et al. Ophthalmologic findings in a large pedigree of 11778/Haplogroup J Leber hereditary optic neuropathy. Am J Ophthalmol. 2004;137:271-277.
22. Salomão SR, Berezovsky A, Andrade RE, Belfort R Jr, Carelli V, Sadun AA. Visual electrophysiologic findings in patients from an extensive Brazilian family with Leber's hereditary optic neuropathy. Doc Ophthalmol. 2004;108:147-155.
23. Ventura DF, Quiros P, Carelli V, et al. Chromatic and luminance contrast sensitivities in asymptomatic carriers from a large Brazilian pedigree of 11778 Leber hereditary optic neuropathy. Invest Ophthalmol Vis Sci. 2005;46:4809-4814.
24. Quiros PA, Torres RJ, Salomao S, et al. Colour vision defects in asymptomatic carriers of the Leber's hereditary optic neuropathy (LHON) mtDNA 11778 mutation from a large Brazilian LHON pedigree: a case-control study. Br J Ophthalmol. 2006; 90:150-153.
25. Guy J, Shaw G, Ross-Cisneros FN, et al. Phosphorylated neurofilament heavy chain is a marker of neurodegeneration in Leber hereditary optic neuropathy (LHON). Mol Vis. 2008;14: 2443-2450.
26. Sacai PY, Salomão SR, Carelli V, et al. Visual evoked potentials findings in non-affected subjects from a large Brazilian pedigree of 11778 Leber's hereditary optic neuropathy. Doc Ophthalmol. 2010;121:147-154.
27. Saadati HG, Hsu HY, Heller KB, Sadun AA. A histopathologic and morphometric differentiation of nerves in optic nerve hypoplasia and Leber hereditary optic neuropathy. Arch Ophthalmol. 1998;116:911-916.
28. Sadun AA, Kashima Y, Wurdeman AE, et al. Morphological findings in the visual system in a case of Leber's hereditary optic neuropathy. Clin Neuro. 1994;2:165-172.
29. Sadun AA, Smith LE, Kenyon KR. Paraphenylenediamine: a new method for tracing human visual pathways. J Neuro-pathol Exp Neurol. 1983;42:200-206.
30. Attwell D, Laughlin SB. An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab. 2001;21: 1133-1145.
31. Lennie P. The cost of cortical computation. Curr Biol. 2003; 13:493-497.
32. Johnson BM, Miao M, Sadun AA. Age-related decline of human optic nerve axon populations. Age. 1987;10:5-9.
33. Mikelberg FS, Drance SM, Schulzer M, Yidegiligne HM, Weis MM. The normal human optic nerve. Axon count and axon diameter distribution. Ophthalmology. 1989;96:1325-1328.
34. Repka MX, Quigley HA. The effect of age on normal human optic nerve fiber number and diameter. Ophthalmology. 1989; 96:26-32.
35. Jonas JB, Müller-Bergh JA, Schlötzer-Schrehardt UM, Naumann GO. Histomorphometry of the human optic nerve. Invest Ophthalmol Vis Sci. 1990;31:736-744.
36. Barboni P, Carbonelli M, Savini G, et al. Natural history of Leber's hereditary optic neuropathy: longitudinal analysis of the retinal nerve fiber layer by optical coherence tomography. Ophthalmology. 2010;117:623-627.
37. Wakakura M, Fujie W, Emoto Y. Initial temporal field defect in Leber hereditary optic neuropathy. Jpn J Ophthalmol. 2009; 53:603-607.
38. Jansonius NM, Nevalainen J, Selig B, et al. A mathematical description of nerve fiber bundle trajectories and their variability in the human retina. Vision Res. 2009;49:2157-2163.
39. Reese BE, Ho KY. Axon diameter distributions across the monkey's optic nerve. Neuroscience. 1988;27:205-214.
40. Sanchez RM, Dunkelberger GR, Quigley HA. The number and diameter distribution of axons in the monkey optic nerve. Invest Ophthalmol Vis Sci. 1986;27:1342-1350.
41. Perge JA, Niven JE, Mugnaini E, Balasubramanian V, Sterling P. Why do axons differ in caliber? J Neurosci. 2012;32:626-638.
42. Perge JA, Koch K, Miller R, Sterling P, Balasubramanian V. How the optic nerve allocates space, energy capacity, and information. J Neurosci. 2009;29:7917-7928.
43. Thanos S, Rohrbach JM, Thiel HJ. Postmortem preservation of ganglion cells in the human retina. A morphometric investigation with the carbocyanine dye DiI. Retina. 1991;11:318-327.
44. Pavlidis M, Stupp T, Hummeke M, Thanos S. Morphometric examination of human and monkey retinal ganglion cells within the papillomacular area. Retina. 2006;26:445-453.
45. Krysko DV, Leybaert L, Vandenabeele P, D'Herde K. Gap junctions and the propagation of cell survival and cell death signals. Apoptosis. 2005;10:459-469.
46. Bloomfield SA, Völgyi B. The diverse functional roles and regulation of neuronal gap junctions in the retina. Nat Rev Neurosci. 2009;10:495-506.
47. Doble A. The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol Ther. 1999;81: 163-221.
48. Barres BA, Hart IK, Coles HS, et al. Cell death and control of cell survival in the oligodendrocyte lineage. Cell. 1992;70:31-46.
49. Barres BA, Schmid R, Sendnter M, Raff MC. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development. 1993;118:283-295.
50. Pinkas-Kramarski R, Eilam R, Spiegler O, et al. Brain neurons and glial cells express Neu differentiation factor/heregulin: a survival factor for astrocytes. Proc Nat Acad Sci U S A. 1994; 91:9387-9391.
51. Yoshida T, Satoh M, Nakagaito Y, Kuno H, Takeuchi M. Cytokines affecting survival and differentiation of an astrocyte progenitor cell line. Brain Res Dev Brain Res. 1993;76:147-150.
52. Arnold AC. Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2003;23:157-163.
53. Ramos Cdo VF, Bellusci C, Savini G, et al. Association of optic disc size with development and prognosis of Leber's hereditary optic neuropathy. Invest Ophthalmol Vis Sci. 2009;50:1666-1674.